Multiple Sclerosis Journal Archives

MediciNova’s Ibudilast Reduces Retinal Thinning in MS Trial Subjects

Cancer Chemotherapy and Pharmacology, Chemotherapy-Induced Peripheral Neuropathy (CIPN), Clinical Data, Clinical Trials, Cytokines, Multiple Sclerosis, Multiple Sclerosis Journal, Peripheral Neuropathy, Progressive Multiple Sclerosis (MS), R&D, Small Molecules

MediciNova received positive Optical Coherence Tomography (OCT) results from the company’s SPRINT-MS Phase IIb trial of MN-166 (ibudilast) in multiple sclerosis subjects.

November 25, 2020/by BioSpace